Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026)
Bausch Health Companies (BHC) reported Change in Acquisitions & Divestments of $1.0 million for Q1 2026, down 75.0% on a YoY basis from $4.0 million in Q1 2025, and down 50.0% sequentially from $2.0 million in Q4 2025.
Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Change in Acquisitions & Divestments data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 75.0% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (down 58.33% YoY), and the FY2025 full-year result was $8.0 million, down 42.86% from the prior year.
- Change in Acquisitions & Divestments retreated to $1.0 million in Q1 2026, from $2.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $13.0 million in Q4 2023 to a low of -$2.0 million in Q2 2023.
- A 5-year average of $4.2 million and a median of $4.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Peak annual rise in Change in Acquisitions & Divestments reached 550.0% in 2023, while the deepest fall reached 128.57% in 2023.
- Tracing BHC's Change in Acquisitions & Divestments over 5 years: stood at $2.0 million in 2022, then surged by 550.0% to $13.0 million in 2023, then tumbled by 76.92% to $3.0 million in 2024, then sank by 33.33% to $2.0 million in 2025, then tumbled by 50.0% to $1.0 million in 2026.
- Business Quant data shows BHC's Change in Acquisitions & Divestments at $1.0 million in Q1 2026, $2.0 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.68 Bn | 367.46 Mn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Dec 31, 2023 | 13.00 Mn |